News · 26 weeks91-79%
2026-03-012026-08-23
Mix4090d
- Insider24(60%)
- SEC Filings8(20%)
- Other3(8%)
- Leadership2(5%)
- Earnings2(5%)
- Dividends1(3%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Perrigo Company plcSCHEDULE 13G/A - PERRIGO Co plc (0001585364) (Subject)
- SECSEC Form 10-Q filed by Perrigo Company plc10-Q - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - PERRIGO Co plc (0001585364) (Filer)
- PRPerrigo Reports Second Quarter 2026 Financial Results From Continuing OperationsExecution of Three-S plan driving continued improvement in underlying business fundamentals, including market share growth in U.S. store-brand OTC and key European brandsStreamlined portfolio through completion of Dermacosmetics divestiture and continuing strategic reviews of Infant Formula and Oral Care businessesReaffirmed full-year 2026 outlook with sequentially stronger second-half performance DUBLIN, Aug. 5, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the second quarter ended June 27, 2026.
- PRPerrigo Announces Quarterly DividendDUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on September 15, 2026, to shareholders of record on August 28, 2026. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care mark
- PRPerrigo to Present at the Canaccord 46th Annual Growth ConferenceDUBLIN, July 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT. The webcast can be accessed on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America an
- INSIDERSEC Form 4 filed by Interim President and CEO Manzone Albert4 - PERRIGO Co plc (0001585364) (Issuer)
- PRPerrigo to Release Second Quarter 2026 Financial Results on August 5, 2026DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider of consumer self-care products, today announced that it plans to release its second quarter 2026 financial results on Wednesday, August 5th, 2026. The company will hold a conference call beginning at 8:30 a.m. (EST) hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra. The earnings conference call will be available live via webcast in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, U.S., 646-357-8785, International, and conference ID
- INSIDERSEC Form 4 filed by Director Amin Ahmed Salman4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by Director Gajial Muhammad Omer4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERNew insider Gajial Muhammad Omer claimed no ownership of stock in the company (SEC Form 3)3 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERNew insider Amin Ahmed Salman claimed no ownership of stock in the company (SEC Form 3)3 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & Chief Financial Officer Bezerra Eduardo Guarita4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and President of CSCI Khoury Roberto4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CBDO Ball David4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, General Counsel & Sec. Atkinson Charles4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, Supply, Ops, Strategy Winterman Matthew John4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CHRO Willis Robert4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CSO Lennox Abigail4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDEREVP, Supply, Ops, Strategy Winterman Matthew John exercised 17,503 units of Ordinary Shares at a strike of $10.52 and covered exercise/tax liability with 9,138 units of Ordinary Shares (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDEREVP and President of CSCI Khoury Roberto exercised 737 units of Ordinary Shares at a strike of $10.52 and covered exercise/tax liability with 385 units of Ordinary Shares, increasing direct ownership by 3% to 14,113 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- SECAmendment: Perrigo Company plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Leadership Update8-K - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PERRIGO Co plc (0001585364) (Filer)
- PRPerrigo Announces Appointment of Two New Independent Directors to BoardDUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent directors, effective June 30, 2026. "We are pleased to welcome Salman and Omer to Perrigo's Board," said Orlando D. Ashford, Chair of Perrigo's Board of Directors. "Both bring deep experience across consumer products, retail, and digital transformation, along with a strong track record of driving growth and operational excellence. Their perspective will be valuable as we continue to advance Perrigo's
PRGO FAQ
6 questionsWhat does Perrigo Company plc do?
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and...Where does PRGO stock trade?
Perrigo Company plc (PRGO) is listed on NYSE.What sector and industry is PRGO in?
Perrigo Company plc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about PRGO?
Perrigo Company plc has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $2000.00 price target on 2025-11-06. Recent price targets range from $2000.00 to $4900.00.What companies are similar to PRGO?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare PRGO side-by-side with any of them on Quantisnow.How can I track PRGO on Quantisnow?
Quantisnow aggregates Perrigo Company plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRGO to receive live email and push alerts on every new disclosure.